Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
The introduction of immune checkpoint inhibitors (ICIs) has represented a major therapeutic breakthrough for patients with mismatch repair-deficient (MMRd) endometrial cancer (EC). However, despite initial clinical success, a considerable subset of patients does not experience meaningful clinical be...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2026-03-01
|
| シリーズ: | Therapeutic Advances in Medical Oncology |
| オンライン･アクセス: | https://doi.org/10.1177/17588359261423888 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|